Research output per year
Research output per year
Personal profile
Education/Academic qualification
Hematology/Oncology, Clinical Fellowship, UCLA Medical Center
Jul 1 2004 → Jun 30 2007
Award Date: Jun 30 2007
Internal Medicine, Residency, LAC-Harbor-UCLA Medical Center
Jun 1 2002 → Jun 30 2004
Award Date: Jun 30 2004
Internal Medicine, Internship, UCLA Medical Center
Jun 1 2001 → Jun 30 2002
Award Date: Jun 30 2002
MD, University of California at Los Angeles School of Medicine
Jul 1 1997 → Jun 30 2001
Award Date: Jun 30 2001
Divisions
- Medical Oncology
Fingerprint
Dive into the research topics where Monisha Singh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Programmed death-ligand 1–high squamous cell carcinoma arising in ovarian teratoma: multi-modal therapy in a rare and aggressive malignancy
Atienza, A. E., Lencina, D., Okoye, E., Kamat, A. & Singh, M., Feb 13 2026, (E-pub ahead of print) In: International Journal of Gynecological Cancer. 36, 7, p. 104600 104600.Research output: Contribution to journal › Comment/debate › peer-review
-
Rethinking the second act: the case for checkpoint inhibitor rechallenge in advanced endometrial cancer
Singh, M., Nov 2025, In: International Journal of Gynecological Cancer. 35, 11Research output: Contribution to journal › Editorial › peer-review
-
1233 Impact of infections occurring in patients receiving immune checkpoint inhibitors for renal cell carcinoma (RCC): SITC 38th Annual Meeting (SITC 2023) Abstracts Regular and Young Investigator Award Abstracts
Wiechmann, C., Gee, K., Burns, E. A., Xu, J., Zhang, Y., Crenshaw, A., Esmail, A., Kieser, R. B., Umoru, G., Muhsen, I., Sun, K., Gong, Z., Shah, S., Singh, M., Zhang, J., Efstathiou, E. & Abdelrahim, M., Nov 2023, In: Journal for immunotherapy of cancer. 11, Suppl 1, p. A1360-A1360 1 p.Research output: Contribution to journal › Meeting Abstract
-
1234 Impact of infections in patients receiving immune checkpoint inhibitor therapies for non-small cell lung cancer (NSCLC): SITC 38th Annual Meeting (SITC 2023) Abstracts Regular and Young Investigator Award Abstracts
Gee, K., Wiechmann, C., Burns, E. A., Xu, J., Zhang, Y., Esmail, A., Crenshaw, A., Kieser, R. B., Umoru, G., Muhsen, I., Sun, K., Gong, Z., Shah, S., Singh, M., Zhang, J., Bernicker, E. & Abdelrahim, M., Nov 2023, In: Journal for immunotherapy of cancer. 11, Suppl 1, p. A1361-A1361 1 p.Research output: Contribution to journal › Conference article
-
480 Impact of infections in patients with advanced or metastatic non-small cell lung cancer (NSCLC) receiving pembrolizumab-based therapies
Burns, E. A., Xu, J., Kieser, R., Muhsen, I., Shah, S., Umoru, G., Mylavarapu, C., Zhang, Y., Crenshaw, A., Sun, K., Esmail, A., Guerrero, C., Gong, Z., Gee, K., Heyne, K., Singh, M., Zhang, J., Bernicker, E. & Abdelrahim, M., Nov 1 2022, In: J Immunother Cancer. 10, Suppl 2, p. A501Research output: Contribution to journal › Article › peer-review